278 related articles for article (PubMed ID: 28797468)
1. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.
Moon DH; Moon SH; Wang K; Weissler MC; Hackman TG; Zanation AM; Thorp BD; Patel SN; Zevallos JP; Marks LB; Chera BS
Oral Oncol; 2017 Sep; 72():98-103. PubMed ID: 28797468
[TBL] [Abstract][Full Text] [Related]
2. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
[TBL] [Abstract][Full Text] [Related]
3. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
[No Abstract] [Full Text] [Related]
4. Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy.
Maesschalck T; Dulguerov N; Caparrotti F; Scolozzi P; Picardi C; Mach N; Koutsouvelis N; Dulguerov P
Head Neck; 2016 Nov; 38(11):1695-1702. PubMed ID: 27240700
[TBL] [Abstract][Full Text] [Related]
5. Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.
Monnier Y; Broome M; Betz M; Bouferrache K; Ozsahin M; Jaques B
Otolaryngol Head Neck Surg; 2011 May; 144(5):726-32. PubMed ID: 21493361
[TBL] [Abstract][Full Text] [Related]
6. Incidence of mandibular osteoradionecrosis (MORN) after intensity modulated radiotherapy (IMRT) versus 3D conformal radiotherapy (3D-CRT): A systematic review.
Céspedes-Ajún CA; Amghar-Maach S; Gay-Escoda C
Med Oral Patol Oral Cir Bucal; 2022 Nov; 27(6):e539-e549. PubMed ID: 36243999
[TBL] [Abstract][Full Text] [Related]
7. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
Owosho AA; Tsai CJ; Lee RS; Freymiller H; Kadempour A; Varthis S; Sax AZ; Rosen EB; Yom SK; Randazzo J; Drill E; Riedel E; Patel S; Lee NY; Huryn JM; Estilo CL
Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
10. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.
Gomez DR; Estilo CL; Wolden SL; Zelefsky MJ; Kraus DH; Wong RJ; Shaha AR; Shah JP; Mechalakos JG; Lee NY
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e207-13. PubMed ID: 21570202
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
[TBL] [Abstract][Full Text] [Related]
12. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2017 Aug; 124(2):232-239. PubMed ID: 28733053
[TBL] [Abstract][Full Text] [Related]
13. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.
Parliament M; Alidrisi M; Munroe M; Wolfaardt J; Scrimger R; Thompson H; Field C; Kurien E; Hanson J
Int J Oral Maxillofac Surg; 2005 Mar; 34(2):114-21. PubMed ID: 15695037
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy and Mandibular Osteoradionecrosis: State of the Art.
De Felice F; Tombolini V; Musio D; Polimeni A
Curr Oncol Rep; 2020 Jul; 22(9):89. PubMed ID: 32642937
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
[TBL] [Abstract][Full Text] [Related]
16. Osteoradionecrosis of mandible in patients treated with definitive radiotherapy for carcinomas of oral cavity and oropharynx. A retrospective study.
Kumar HS; Bihani V; Kumar V; Chaudhary RK; Kumar L; Punia DP
Indian J Dent Res; 1992; 3(2):47-50. PubMed ID: 1343958
[TBL] [Abstract][Full Text] [Related]
17. Frequency of osteoradionecrosis of the lower jaw after radiotherapy of oral cancer patients correlated with dosimetric parameters and other risk factors.
Lang K; Held T; Meixner E; Tonndorf-Martini E; Ristow O; Moratin J; Bougatf N; Freudlsperger C; Debus J; Adeberg S
Head Face Med; 2022 Feb; 18(1):7. PubMed ID: 35219324
[TBL] [Abstract][Full Text] [Related]
18. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.
Tsai CJ; Hofstede TM; Sturgis EM; Garden AS; Lindberg ME; Wei Q; Tucker SL; Dong L
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):415-20. PubMed ID: 22795804
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of severity of osteoradionecrosis of the mandible.
Chopra S; Kamdar D; Ugur OE; Chen G; Peshek B; Marunick M; Kim H; Lin HS; Jacobs J
Head Neck; 2011 Nov; 33(11):1600-5. PubMed ID: 21484922
[TBL] [Abstract][Full Text] [Related]
20. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
Ahmed M; Hansen VN; Harrington KJ; Nutting CM
Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
